tradingkey.logo

Neuropace Inc

NPCE
View Detailed Chart

8.975USD

-0.015-0.17%
Market hours ETQuotes delayed by 15 min
293.94MMarket Cap
LossP/E TTM

Neuropace Inc

8.975

-0.015-0.17%
Intraday
1m
30m
1h
D
W
M
D

Today

-0.17%

5 Days

-0.06%

1 Month

-13.62%

6 Months

-34.06%

Year to Date

-19.79%

1 Year

+29.14%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 8 analysts
BUY
Current Rating
17.286
Target Price
92.28%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

95
Total
4
Median
7
Average
Company name
Ratings
Analysts
Neuropace Inc
NPCE
8
Boston Scientific Corp
BSX
36
Edwards Lifesciences Corp
EW
35
Intuitive Surgical Inc
ISRG
34
Veeva Systems Inc
VEEV
32
Thermo Fisher Scientific Inc
TMO
31
1
2
3
...
19

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Sell
Sell(6)
Neutral(4)
Buy(3)
Indicators
Sell(1)
Neutral(4)
Buy(2)
Indicators
Value
Direction
MACD(12,26,9)
0.105
Neutral
RSI(14)
38.091
Neutral
STOCH(KDJ)(9,3,3)
31.760
Buy
ATR(14)
0.390
High Vlolatility
CCI(14)
-83.968
Neutral
Williams %R
45.588
Neutral
TRIX(12,20)
-0.924
Sell
StochRSI(14)
100.000
Buy
Moving Average
Sell(5)
Neutral(0)
Buy(1)
Indicators
Value
Direction
MA5
8.756
Buy
MA10
9.004
Sell
MA20
9.327
Sell
MA50
11.134
Sell
MA100
11.672
Sell
MA200
11.204
Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

NeuroPace, Inc. is a medical device company. The Company is focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is a brain-responsive platform that delivers personalized, real-time treatment at the seizure source. The Company has developed its RNS System to address the individualized nature of drug-resistant epilepsy and deliver a safe therapy for focal onset seizures anywhere in the brain. The RNS System is a device that records brain activity data and allows clinicians to monitor patients not only in person, but also remotely. RNS System monitors and analyzes the brain’s electrical activity, recognizes patient-specific abnormal patterns, and delivers treatment at the seizure source. The Company’s RNS System is also engaged in treating other brain disorders, including depression, impulse control disorders, memory disorders, and post-traumatic stress disorder.
Ticker SymbolNPCE
CompanyNeuropace Inc
CEOMr. Joel D. Becker
Websitehttps://www.neuropace.com/
KeyAI